Status:
UNKNOWN
Diagnostic and Evaluation of Hepato-pancreatico-biliary Disease With MRI
Lead Sponsor:
University of Zurich
Conditions:
Liver Diseases
Pancreas Disease
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective review of images from patient data. There is no recruitment necessary for this study. Research Question: Can advanced multiparametric MRI techniques improve the detection and ...
Eligibility Criteria
Inclusion
- Patients with suspicion for or diagnosed focal and/or diffuse liver or pancreatic disease who underwent MRI of the abdomen.
- 18 years of age and older.
Exclusion
- Age less than 18 years.
- Lack of MRI of the abdomen.
- Inadequate image quality.
- Documented rejection to participate in research studies
Key Trial Info
Start Date :
June 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04701567
Start Date
June 30 2020
End Date
December 30 2023
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091